![]() |
市场调查报告书
商品编码
1894883
生物医学与资讯通信技术融合市场:按技术、解决方案和地区划分(2025-2030 年)Biomedical and ICT Convergence Market by Technology, Solution and Region 2025 - 2030 |
||||||
本报告评估了资讯通信技术 (ICT) 产业与生物医学科学技术的融合。报告总结了生物医学领域的发展趋势,并从互联医疗设备等资讯通信技术创新角度分析了资讯通信技术行业。报告还预测了物联网互联医疗设备(独立式、穿戴式和植入式)的发展趋势,并评估了有望受益于各种资讯科技和通讯技术的生物医学产品、服务和解决方案的前景。
生物医学领域是一个高度交叉的领域,融合了生物学、化学和物理学等多种自然科学,旨在增进我们对人类健康的理解。 其根本目标是开发创新干预措施、疗法和医疗技术,以改善临床实践。
顺应这一趋势,Mind Commerce 将资讯通信技术 (ICT) 行业视为涵盖广泛通讯和计算基础设施的领域,并专注于数据管理中硬体和软体的无缝整合。该领域通常被归类于更广泛的科技、媒体和电信 (TMT) 领域,TMT 指的是数位系统、广播媒体和资料传输的整合。这些产业共同构成了现代数位商务、内容分发和互动应用的基础。
生物医学科学与资讯通信技术 (ICT) 的有意融合,代表着医疗保健和科技行业的突破性转变,创造了一个以跨学科创新为特征的高增长领域。除了根除疾病和预防慢性病等传统目标之外,这两个领域的整合旨在提高医疗程序的精确度。
透过利用数位工具,医疗保健提供者可以提高整体护理效率,同时简化医疗服务的物流。 这种协同作用不仅使医疗服务更加高效,而且更加便捷和系统化,将患者体验从碎片化转变为连贯的、数据驱动的过程。
应对现代医疗保健的经济挑战或许是推动这项技术整合的最迫切因素。医疗保健成本持续高于通货膨胀率,威胁全球医疗保健系统的可持续性。因此,在减轻治疗经济负担的同时改善患者疗效至关重要。
这包括优化营运支出,并降低与研发相关的巨额成本。在药物发现和疫苗开发等领域,精准医疗(根据每个人的基因谱量身定制治疗方案)的应用至关重要。这减少了通常与 "一刀切" 的医疗模式相关的资源浪费。
物联网 (IoT) 是资讯通信技术 (ICT) 在临床环境中实际应用的典范。支援物联网的设备可以即时监测患者对各种治疗的反应。这种细緻的监测在引入新的或未经检验的医疗方法时至关重要。
相关的例子包括疫苗接种和表观遗传学研究的进展。表观遗传学研究的是环境因素和行为如何影响基因表达,而不改变DNA序列本身。虽然像疫苗接种这样的医疗干预措施旨在预防疾病,但资讯通信技术(ICT)工具可以识别出少数人群,他们独特的表观遗传标记可能会无意中影响其生理结果。
在这个融合领域中最具活力的子领域之一是无线IP行动和穿戴式技术的广泛应用。结合先进的植入式感测器,这些技术能够以前所未有的水平进行持续的生理监测,这在医学领域尚属首次。
这些互联设备可作为临床决策支援和自动化治疗管理的综合平台。透过向医疗保健专业人员提供持续不断的高精度资料流,它们能够帮助做出更明智的诊断并快速调整治疗方案。
最终,这些数位工具在被动式和预防式医疗保健框架中都将同样有效。 在前者中,它们能够透过自动胰岛素滴定来管理糖尿病等慢性疾病。在后者中,它们能够优化疫苗接种计划并改进疫苗配方,从而在疾病发生之前就进行预防。
因此,资讯通信技术与生物医学的融合有望带来双重益处:一方面,透过降低成本和开发新型疗法来稳定医疗经济,另一方面,透过数据驱动的个人化医疗来提升全球公共卫生水平。
This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies. The report evaluates the latter and analyzes the former in terms of ICT innovation such as connected medical devices. In addition to forecasts for IoT connected healthcare devices (standalone, wearable, and implantable), the report also assesses the outlook for various biomedical products, services, and solutions poised to benefit from various IT and telecom technologies.
The field of biomedicine represents a sophisticated intersection of various natural science disciplines, including biology, chemistry, and physics, synthesized to advance our understanding of human health. It is fundamentally dedicated to the creation of innovative interventions, therapeutic modalities, and medical technologies that enhance clinical practice.
Parallel to this dynamic, Mind Commerce sees the Information and Communications Technology (ICT) sector encompassing the vast infrastructure of telecommunications and computing, focusing on the seamless integration of hardware and software to manage data. This sector is often categorized within the broader TMT framework-Technology, Media, and Telecommunications, which accounts for the convergence of digital systems, broadcast media, and data transmission. Together, these industries form the backbone of modern digital commerce, content distribution, and interactive applications.
The deliberate convergence of biomedical science and ICT signifies a monumental shift for both the healthcare and technology industries, creating a high-growth area characterized by cross-disciplinary innovation. Beyond the traditional objectives of eradicating diseases and preventing chronic ailments, the marriage of these fields is designed to enhance the precision of medical treatments.
By leveraging digital tools, providers can improve the overall efficacy of care while streamlining the logistics of healthcare delivery. This synergy ensures that medical services are not only more effective but also more accessible and systematically organized, transforming the patient experience from a fragmented process into a cohesive, data-driven journey.
Addressing the economic challenges of modern medicine is perhaps the most urgent driver of this technological integration. Healthcare expenditures consistently outpace general inflation, threatening the sustainability of global health systems. Consequently, there is a critical need to improve patient outcomes while simultaneously reducing the financial burden of care.
This involves optimizing operational expenditures and mitigating the immense costs associated with research and development. In areas like pharmaceutical drug discovery and vaccine development, the application of precision medicine, which tailors treatment to individual genetic profiles, is essential for reducing the wasted resources often found in "one-size-fits-all" medical models.
The practical application of ICT in clinical settings often manifests through the Internet of Things (IoT), where enabled devices monitor patient responses to various procedures in real time. Such granular monitoring is vital when introducing new or unproven healthcare modalities.
A pertinent example involves vaccine administration and the emerging study of epigenetics, which examines how environmental factors and behaviors influence gene expression without altering the underlying DNA sequence. While a medical intervention like a vaccine is designed with the singular, positive intent of disease inoculation, ICT tools can help identify the minute subset of the population that might experience unintended physiological consequences due to their unique epigenetic markers.
One of the most dynamic subsectors of this convergence is the proliferation of wireless, IP-enabled handheld devices and wearable technologies. These tools, alongside sophisticated implantable sensors, offer a level of continuous physiological monitoring that was previously impossible in the history of medical science.
These connected devices serve as comprehensive platforms for clinical decision support and automated treatment administration. By providing clinicians with a constant stream of high-fidelity data, these technologies allow for more informed diagnoses and more rapid adjustments to treatment plans.
Ultimately, these digital tools are equally effective across both reactive and proactive medical frameworks. In reactive care, they can manage chronic conditions like diabetes through automated insulin modification; in proactive care, they can optimize vaccine schedules and formulations to prevent illness before it occurs.
The integration of ICT and biomedicine is therefore expected to yield a dual benefit: it will stabilize the economics of healthcare by lowering costs and uncovering new revenue streams through novel treatments, while simultaneously elevating the standards of global public health through personalized, data-centric care.